Pfizer Offered $99 Billion In AstraZeneca Bid - Presented by: The Aol. On Network

Pfizer confirmed today that it had asked AstraZeneca to consider a merger, and been rebuffed. Under U.K. law, it had to disclose the offer and went public with a $98.7 billion offer to buy the London-based drug maker. The deal will be 70% cash and 30% stock, and will provide Pfizer with a way to use funds it has kept out of the U.S. without paying U.S. taxes. The deal would also allow Pfizer to lower its tax rate by creating a holding company in the U.K.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
FCX $ 10.50 0.31 ▲ 3.04%
ATVI $ 29.22 1.29 ▲ 4.62%
BAC $ 16.36 0.08 ▼ 0.49%
AAPL $ 113.29 0.37 ▲ 0.33%
BTU $ 2.39 0.11 ▲ 4.82%
PBR $ 5.78 0.05 ▲ 0.87%
QQQ $ 105.62 0.02 ▼ 0.02%
INTC $ 28.42 0.70 ▲ 2.53%

As of 8/28/2015, 04:15 PM